0

543828

SUDARSHAN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUDARSHAN PHARMA INDUSTRIES LI Share Price Today

Investment Returns

Over 1 Month 18.34% Over 3 Months 58.78% Over 6 Months 63.01% Over 1 Year 26.15%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SUDARSHAN PHARMA INDUSTRIES LI fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 949.20
  • P/E Ratio (TTM) 43.34
  • Beta 0.56
  • Book Value / share 6.34
  • Return on equity 14.79%
  • EPS (TTM) 0.91
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 9.54
info icon alternate text

SUDARSHAN PHARMA INDUSTRIES LI Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 199.81
Operating Expense 189.78
Net Profit 9.54
Net Profit Margin (%) 4.77
Earnings Per Share (EPS) 0.40
EBITDA 21.50
Effective Tax Rate (%) 27.89
Particulars DEC 2025 (Values in Cr)
Revenue 158.37
Operating Expense 154.64
Net Profit 4.31
Net Profit Margin (%) 2.72
Earnings Per Share (EPS) 0.18
EBITDA 12.47
Effective Tax Rate (%) 20.47
Particulars SEP 2025 (Values in Cr)
Revenue 167.01
Operating Expense 164.26
Net Profit 4.40
Net Profit Margin (%) 2.63
Earnings Per Share (EPS) 0.18
EBITDA 11.71
Effective Tax Rate (%) 8.69
Particulars JUN 2025 (Values in Cr)
Revenue 142.31
Operating Expense 138.53
Net Profit 3.73
Net Profit Margin (%) 2.62
Earnings Per Share (EPS) 0.15
EBITDA 11.69
Effective Tax Rate (%) 28.13
Particulars MAR 2025 (Values in Cr)
Revenue 161.57
Operating Expense 151.55
Net Profit 7.03
Net Profit Margin (%) 4.35
Earnings Per Share (EPS) 0.29
EBITDA 14.47
Effective Tax Rate (%) 24.27
Particulars MAR 2026 (Values in Cr)
Revenue 667.50
Operating Expense 647.24
Net Profit 21.98
Net Profit Margin (%) 3.29
Earnings Per Share (EPS) 0.91
EBITDA 57.37
Effective Tax Rate (%) 23.33
Particulars MAR 2025 (Values in Cr)
Revenue 502.49
Operating Expense 483.87
Net Profit 14.02
Net Profit Margin (%) 2.79
Earnings Per Share (EPS) 0.58
EBITDA 37.73
Effective Tax Rate (%) 25.41
Particulars MAR 2024 (Values in Cr)
Revenue 465.56
Operating Expense 453.21
Net Profit 11.36
Net Profit Margin (%) 2.44
Earnings Per Share (EPS) 4.72
EBITDA 25.36
Effective Tax Rate (%) 24.76
Particulars MAR 2023 (Values in Cr)
Revenue 461.33
Operating Expense 452.95
Net Profit 7.04
Net Profit Margin (%) 1.52
Earnings Per Share (EPS) 5.46
EBITDA 15.81
Effective Tax Rate (%) 25.89
Particulars MAR 2022 (Values in Cr)
Revenue 357.09
Operating Expense 350.42
Net Profit 5.25
Net Profit Margin (%) 1.47
Earnings Per Share (EPS) 5.46
EBITDA 11.38
Effective Tax Rate (%) 26.47
Particulars MAR 2025 (Values in Cr)
Book Value / Share 5.30
ROE % 14.82
ROCE % 15.48
Total Debt to Total Equity 1.13
EBITDA Margin 8.40
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.42
ROE % 10.78
ROCE % 13.73
Total Debt to Total Equity 0.65
EBITDA Margin 5.48
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.96
ROE % 10.77
ROCE % 15.24
Total Debt to Total Equity 0.49
EBITDA Margin 3.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.54
ROE % 20.08
ROCE % 18.67
Total Debt to Total Equity 1.15
EBITDA Margin 3.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.58
ROE % 12.61
ROCE % 14.63
Total Debt to Total Equity 1.19
EBITDA Margin 3.90
Particulars MAR 2025 (Values in Cr)
Book Value / Share 5.30
ROE % 14.79
ROCE % 15.30
Total Debt to Total Equity 1.15
EBITDA Margin 8.23
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.38
ROE % 10.69
ROCE % 13.63
Total Debt to Total Equity 0.66
EBITDA Margin 5.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.96
ROE % 10.77
ROCE % 15.24
Total Debt to Total Equity 0.49
EBITDA Margin 3.43
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.55
ROE % 20.08
ROCE % 18.67
Total Debt to Total Equity 1.15
EBITDA Margin 3.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.58
ROE % 12.61
ROCE % 14.63
Total Debt to Total Equity 1.19
EBITDA Margin 3.90
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.55
Total Assets 402.40
Total Liabilities 402.40
Total Equity 131.48
Share Outstanding 24
Price to Book Ratio 5.76
Return on Assets (%) 3.96
Return on Capital (%) 5.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 283.12
Total Liabilities 283.12
Total Equity 111.70
Share Outstanding 2
Price to Book Ratio 1.60
Return on Assets (%) 4.04
Return on Capital (%) 5.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 232.47
Total Liabilities 232.47
Total Equity 100.97
Share Outstanding 2
Price to Book Ratio 1.33
Return on Assets (%) 3.02
Return on Capital (%) 5.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.23
Total Assets 137.52
Total Liabilities 137.52
Total Equity 29.77
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.81
Return on Capital (%) 8.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.25
Total Assets 99.26
Total Liabilities 99.26
Total Equity 22.55
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 5.42
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 400.39
Total Liabilities 400.39
Total Equity 131.31
Share Outstanding 24
Price to Book Ratio 5.76
Return on Assets (%) 3.96
Return on Capital (%) 5.22
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 284.84
Total Liabilities 284.84
Total Equity 111.61
Share Outstanding 2
Price to Book Ratio 1.60
Return on Assets (%) 3.98
Return on Capital (%) 5.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 232.46
Total Liabilities 232.46
Total Equity 100.98
Share Outstanding 2
Price to Book Ratio 1.33
Return on Assets (%) 3.02
Return on Capital (%) 5.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 137.51
Total Liabilities 137.51
Total Equity 29.78
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.81
Return on Capital (%) 8.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.15
Total Assets 99.21
Total Liabilities 99.21
Total Equity 22.50
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.69
Return on Capital (%) 5.11
Particulars MAR 2025 (Values in Cr)
Net Income 21.62
Cash from Operations 38.16
Cash from Investing -20.40
Cash from Financing -14.44
Net change in Cash 0.36
Free Cash Flow 38.74
Particulars MAR 2024 (Values in Cr)
Net Income 15.22
Cash from Operations 9.90
Cash from Investing -7.23
Cash from Financing -12.09
Net change in Cash -11.57
Free Cash Flow 11.82
Particulars MAR 2023 (Values in Cr)
Net Income 9.49
Cash from Operations -26.68
Cash from Investing -25.65
Cash from Financing 65.92
Net change in Cash 11.48
Free Cash Flow -12.36
Particulars MAR 2022 (Values in Cr)
Net Income 7.13
Cash from Operations -2.05
Cash from Investing -1.45
Cash from Financing 4.26
Net change in Cash -1.01
Free Cash Flow -0.93
Particulars MAR 2021 (Values in Cr)
Net Income 3.57
Cash from Operations 3.60
Cash from Investing -1.29
Cash from Financing -1.48
Net change in Cash -0.01
Free Cash Flow 4.92
Particulars MAR 2025 (Values in Cr)
Net Income 21.28
Cash from Operations 37.74
Cash from Investing -20.24
Cash from Financing -14.40
Net change in Cash 0.25
Free Cash Flow 38.27
Particulars MAR 2024 (Values in Cr)
Net Income 15.09
Cash from Operations 11.80
Cash from Investing -9.08
Cash from Financing -12.18
Net change in Cash -11.57
Free Cash Flow 13.72
Particulars MAR 2023 (Values in Cr)
Net Income 9.49
Cash from Operations -26.68
Cash from Investing -25.65
Cash from Financing 65.92
Net change in Cash 11.48
Free Cash Flow -12.35
Particulars MAR 2022 (Values in Cr)
Net Income 7.13
Cash from Operations -1.93
Cash from Investing -1.53
Cash from Financing 4.30
Net change in Cash -0.92
Free Cash Flow -0.81
Particulars MAR 2021 (Values in Cr)
Net Income 3.57
Cash from Operations 3.71
Cash from Investing -1.34
Cash from Financing -1.63
Net change in Cash -0.11
Free Cash Flow 5.03
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ATUL LTD 6490.10 28.19 3.07 19107.99 5563.00 7793.00
BASF INDIA LTD 3492.00 36.31 3.81 15115.35 2906.90 5251.00
ORIENTAL AROMATICS LTD 343.75 350.77 1.74 1156.84 227.05 421.60
DEEPAK FERTILISERS & PETROCHEM 1560.65 26.72 2.87 19701.31 865.45 1776.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ADVANCE PETROCHEMICALS LTD. 270.70 0.00 6.13 24.36 97.60 320.75
ATUL LTD 6490.10 32.11 3.15 19107.99 5563.00 7793.00
BASF INDIA LTD 3492.00 36.25 3.80 15115.35 2906.90 5251.00
ORIENTAL AROMATICS LTD 343.75 45.77 1.64 1156.84 227.05 421.60

SUDARSHAN PHARMA INDUSTRIES LI shareholding pattern

Holding
22.66%
57.38%
19.94%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SUDARSHAN PHARMA INDUSTRIES LI Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
39.44 -1.27 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 38.70
  • 26 Days 35.70
  • 10 Days 37.80
  • 50 Days 33.50
  • 12 Days 37.50
  • 100 Days 30.90
  • 20 Days 36.40
  • 200 Days 29.30
37.09 PIVOT
First Support 36.39 First Resistance 37.69 Second Support 35.79 Second Resistance 38.39 Third Support 35.09 Third Resistance 38.99
RSI 63.83 ADX 9.50 MACD 1.48 Williams % R -24.29 Commodity Channel Index (CCI) 61.16
Date 2026-06-19 Week 259333.00 Same Day 384000.00 Month 190609.00
1 Year 0.56 3 Year 0.55
Over 1 Month
18.34% down
Over 1 Year
26.15% down
Over 3 Months
58.78% down
Over 3 Years
75.25% down
Over 6 Months
63.01% down
Over 5 Years
0.00% down

SUDARSHAN PHARMA INDUSTRIES LI Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
25 Aug 2023 0.3 Final 26 Aug 2023 Equity shares
Ex-Date Old FV NEW FV Record Date
22 Nov 2024 10.0 1.0 23 Nov 2024

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sudarshan Pharma Industries Ltd?

Answer Field

Sudarshan Pharma Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 39.44 as on Jun 25 2026 02:44 PM.

What is the Market Cap of Sudarshan Pharma Industries Ltd Share?

Answer Field

The market cap of Sudarshan Pharma Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 949.20 as on Jun 25 2026 02:44 PM.

What is the 52 Week High and Low of Sudarshan Pharma Industries Ltd?

Answer Field

The 52 Week High and Low of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 40.41 and ₹ 18.50.

What is 1 year return for Sudarshan Pharma Industries Ltd?

Answer Field

The 1 year returns on the stock has been 42.22%.

What is the P/E Ratio of Sudarshan Pharma Industries Ltd Share?

Answer Field

As on Jun 25 2026 02:44 PM the price-to-earnings (PE) ratio for Sudarshan Pharma Industries Ltd share is 43.34.

What is the PB ratio of Sudarshan Pharma Industries Ltd Share?

Answer Field

As on Jun 25 2026 02:44 PM, the price-to-book (PB) ratio for Sudarshan Pharma Industries Ltd share is 6.34.

How to Buy Sudarshan Pharma Industries Ltd Share?

Answer Field

You can trade in Sudarshan Pharma Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sudarshan Pharma Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Sudarshan Pharma Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sudarshan Pharma Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|